|
|
Prepublished online as a Blood First Edition Paper on April 17, 2002; DOI 10.1182/blood-2001-11-0093.

Submitted November 29, 2001
Accepted March 21, 2002
HOX11L2 expression defines a clinical subtype of pediatric T-ALL which is associated with poor prognosis
Paola Ballerini, Annick Blaise, Maryvonne Busson-LeConiat, Xin Ying Su, Jessica Zucman-Rossi, Adam Mircea, Jacqueline van den Akker, Christine Perrot, Beatrice Pellegrino, Judith Landman-Parker, Luc Douay, Roland Berger, and Olivier A Bernard*
Hopital Armand Trousseau, Service d'Hematologie Biologique, Paris, France; 27 Rue Juliette Dodu, Unite 434 INSERM-CEPH and SD401 N-434 CNRS, Paris, France
Universite Paris 6, UPRES A1638, Paris, France
27 Rue Juliette Dodu, Unite 434 INSERM-CEPH and SD401 N-434 CNRS, Paris, France; Faculté Necker - Enfants Malades, Present address: EMI INSERM 0210, Paris, France
27 Rue Juliette Dodu, Unite 434 INSERM-CEPH and SD401 N-434 CNRS, Paris, France
Hopital Armand Trousseau, Service d'Hematologie Biologique, Paris, France
Hopital Saint Antoine, Service de cytogenetique, Paris, France
Hopital Armand Trousseau, Service d'Hematologie et d'Oncologie pediatrique, Paris, France
Hopital Armand Trousseau, Service d'Hematologie et d'Oncologie pediatrique, Paris, France; Universite Paris 6, UPRES A1638, Paris, France
* Corresponding author; email: bernard{at}cephb.fr.
The most frequent oncogenic activation events characterized in childhood T acute lymphoblastic leukemia (T-ALL), result in the transcriptional activation of genes coding for transcription factors. The main genes are TAL1/SCL a member of the basic region Helix-Loop-Helix gene family and HOX11L2, a member of homeobox containing protein family. To gain insight into the pathogenesis of this type of hematological malignancy, we analyzed 28 T-ALL samples. The SIL-TAL1/SCL fusion is detected in 6 patients; the expression of HOX11L2 is observed in 6 patients and of HOX11 in 3 patients. With one exception, these activations did not occur simultaneously in the same patients and allowed the sub-classification of 50 % of the patients. The SIL-TAL1 fusion was detected in association with weak HOX11 expression in one case and with a t(8;14)(q24;q11) in another. High expression of LYL1, LMO2 or TAL1 was mainly observed in samples negative for HOX11L2. HOX11L1 and HOX11 expression were observed in one instance each, in the absence of detectable chromosome abnormality of their respective loci, on chromosome 2 and 10, respectively. HOX11L2 expression is associated with a chromosome 5q abnormality, the location of the HOX11L2 locus in each case tested. Finally, our data show that HOX11L2 expression is a suitable marker for minimal residual disease follow up and is significantly associated with relapse (p=0.02).

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Su, V. Della-Valle, E. Delabesse, Z. Azgui, R. Berger, H. Merle-Beral, O. A Bernard, and F. Nguyen-Khac
Transcriptional activation of the cardiac homeobox gene CSX1/NKX2-5 in a B-cell chronic lymphoproliferative disorder
Haematologica,
July 1, 2008;
93(7):
1081 - 1085.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Baldus, T. Burmeister, P. Martus, S. Schwartz, N. Gokbuget, C. D. Bloomfield, D. Hoelzer, E. Thiel, and W. K. Hofmann
High Expression of the ETS Transcription Factor ERG Predicts Adverse Outcome in Acute T-Lymphoblastic Leukemia in Adults
J. Clin. Oncol.,
October 10, 2006;
24(29):
4714 - 4720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Borghini, M. Vargiolu, M. Di Duca, R. Ravazzolo, and I. Ceccherini
Nuclear Factor Y Drives Basal Transcription of the Human TLX3, a Gene Overexpressed in T-Cell Acute Lymphocytic Leukemia
Mol. Cancer Res.,
September 1, 2006;
4(9):
635 - 643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Zhu, W.-L. Zhao, J.-F. Fu, J.-Y. Shi, Q. Pan, J. Hu, X.-D. Gao, B. Chen, J.-M. Li, S.-M. Xiong, et al.
NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis.
Clin. Cancer Res.,
May 15, 2006;
12(10):
3043 - 3049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Asnafi, A. Buzyn, X. Thomas, F. Huguet, N. Vey, J.-M. Boiron, O. Reman, J.-M. Cayuela, V. Lheritier, J.-P. Vernant, et al.
Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study
Blood,
April 15, 2005;
105(8):
3072 - 3078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chiaretti, X. Li, R. Gentleman, A. Vitale, M. Vignetti, F. Mandelli, J. Ritz, and R. Foa
Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival
Blood,
April 1, 2004;
103(7):
2771 - 2778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nagel, M. Kaufmann, H. G. Drexler, and R. A. F. MacLeod
The Cardiac Homeobox Gene NKX2-5 Is Deregulated by Juxtaposition with BCL11B in Pediatric T-ALL Cell Lines via a Novel t(5;14)(q35.1;q32.2)
Cancer Res.,
September 1, 2003;
63(17):
5329 - 5334.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|